Digital breast tomosynthesis (DBT) represent a new breast imaging technology recently approved by the FDA with the potential to increase cancer detection while significantly reducing the need for call back and follow up examinations. The Breast Imaging Division at the Hospital of the University of Pennsylvania will transition its screening practice that to DBT. Project 1 will take advantage of the transition DBT to measure screening related outcomes, xray dose and costs associated with routine DBT based screening and compare it to a cohort screened with planar digital mammography (DM). During the transition, patients will either undergo DBT or DM screening on a first come first serve basis. The comparison cohort will be the population screened at HUP with DM. Screening outcomes measured include call backs, follow ups, Ultrasound exams, biopsies and cancer. Mean gladular xray dose will be calculated for every projection of DM and DBT exams. Costs associated with the screening exam, and downstream costs associated with the diagnostic work up will be measured in both cohorts. Patients will be surveyed to determine the effect of DBT on satisfaction with the screening process and breast cancer worry. Given the lack of data related to the impact of DBT on breast cancer screening outcomes, project 1 will generate critical data to inform the more widespread implementation of this new technology.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-R)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Wood, Marie E; Sprague, Brian L; Oustimov, Andrew et al. (2017) Aspirin use is associated with lower mammographic density in a large screening cohort. Breast Cancer Res Treat 162:419-425
Conant, Emily F; Keller, Brad M; Pantalone, Lauren et al. (2017) Agreement between Breast Percentage Density Estimations from Standard-Dose versus Synthetic Digital Mammograms: Results from a Large Screening Cohort Using Automated Measures. Radiology 283:673-680
Balasubramanian, Bijal A; Garcia, Michael P; Corley, Douglas A et al. (2017) Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore) 96:e6326
Weiss, Julie E; Goodrich, Martha; Harris, Kimberly A et al. (2017) Challenges With Identifying Indication for Examination in Breast Imaging as a Key Clinical Attribute in Practice, Research, and Policy. J Am Coll Radiol 14:198-207.e2
McDonald, Elizabeth S; McCarthy, Anne Marie; Weinstein, Susan P et al. (2017) BI-RADS Category 3 Comparison: Probably Benign Category after Recall from Screening before and after Implementation of Digital Breast Tomosynthesis. Radiology 285:778-787
Haas, Jennifer S; Barlow, William E; Schapira, Marilyn M et al. (2017) Primary Care Providers' Beliefs and Recommendations and Use of Screening Mammography by their Patients. J Gen Intern Med 32:449-457
Chudgar, A V; Conant, E F; Weinstein, S P et al. (2017) Assessment of disease extent on contrast-enhanced MRI in breast cancer detected at digital breast tomosynthesis versus digital mammography alone. Clin Radiol 72:573-579
Klabunde, Carrie N; Zheng, Yingye; Quinn, Virginia P et al. (2016) Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med 51:e67-75
Korhonen, Katrina E; Weinstein, Susan P; McDonald, Elizabeth S et al. (2016) Strategies to Increase Cancer Detection: Review of True-Positive and False-Negative Results at Digital Breast Tomosynthesis Screening. Radiographics 36:1954-1965
Haas, Jennifer S; Sprague, Brian L; Klabunde, Carrie N et al. (2016) Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines. J Gen Intern Med 31:52-9

Showing the most recent 10 out of 45 publications